Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects

Journal of Clinical Investigation

Volumn 96, Issue 4, 1995, Pages 1859-1865

  Nozaki, Shuichi ^a   Kashiwagi, Hirokazu ^a   Yamashita, Shizuya ^a   Nakagawa, Tsutomu ^a   Kostner, Bernd ^a   Tomiyama, Yoshiaki ^a   Nakata, Atsuyuki ^a   Ishigami, Masato ^a   Miyagawa, Jun Ichiro ^a   Kameda Takemura, Kaoru ^a   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

acetyl LDL receptor; CD36 deficiency; foam cell formation; macrophage; oxidized LDL receptor

Indexed keywords

CD36 ANTIGEN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; LIPID OXIDATION; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0028834455     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118231     Document Type: Article

References (40)

1. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:181-190.
2. Faggiotto, A., R. Ross, and L. Harker. 1984. Studies of hypercholesterolemia in the nonhuman primate I. Changes that lead to fatty streak formation. Arteriosclerosis. 4:323-340.
3. Schaffner, T., K. Taylor, J. Bartucci, K. Fischer-Dzoga, J. H. Beeson, S. Glagov, and R. W. Wissler. 1980. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100:57-80.
4. Takahashi, K., M. Naito, T. Kodama, H. Suzuki, T. Mori, and A. Matsumoto. 1992. Expression of macrophage scavenger receptors in various human tissues and atherosclerotic lesions. Clin. Biochem. 25:365-368.
5. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:333-337.
6. Kodama, T., P. Reddy, P. C. Kishimoto, and M. Krieger. 1988. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 85:9238-9242.
7. Kodama, T., M. Freeman, L. Rohrer, J. Zabrewcky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature (Lond.). 343:531-535.
8. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78:6499-6503.
9. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells. Proc. Natl. Acad. Sci. USA. 81:3883-3887.
10. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. An antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that anti-oxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc. Natl. Acad. Sci. USA. 84:7725-7729.
11. Kita, T., Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, S. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:5928-5931.
12. Palinski, W., M. E. Rosenfeld, S. Yla-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1376.
13. Arai, H., T. Kita, M. Yokode, S. Narumiya, and C. Kawai. 1989. Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages; different uptake mechanisms for acetylated and oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 159:1375-1382.
14. Sparrow, C. P., S. Parthasarathy, and D. Steinberg. 1989. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264:2599-2604.
15. Stanton, L. W., R. T. White, C. M. Bryant, A. A. Protteer, and G. Endemann. 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267:22446-22451.
16. Greenwalt, D. E., R. H. Lipsky, C. F. Ockenhouse, H. Ikeda, N. N. Tandon, and G. A. Jamieson. 1992. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood. 80:1105-1115.
17. Savil, J., N. Hogg, and C. Haslett. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-1522.
18. McKeown, L., M. Vail, W. Kramer, K. Hansmann, and H. Gralnick. 1994. Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood. 83:2866-2871.
19. Oquendo, P., E. Hundt, J. Lawler, and B. Seed. 1989. CD36 directly mediates cytoadherence of plasmodium falciparum parasitized erythrocytes. Cell. 58:95-101.
20. Tandon, N. N., U. Kralisz, and G. A. Jamieson. 1989. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264:7576-7583.
21. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang. 57:213-217.
22. a. on platelet membrane glycoprotein IV. Blood. 75:684-687.
23. a. Br. J. Haematol. 84:387-392.
24. Kashiwagi, H., S. Honda, Y. Tomiyama, H. Mizutani, H. Take, Y. Honda, S. Kosugi, Y. Kanayama, Y. Kurata, and Y. Matsuzawa. 1993. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV. Thromb. Haemostas. 69:481-484.
25. Kashiwagi, H., Y. Tomiyama, Y. Kosugi, M. Shiraga, R. H. Lipsky, Y. Kanayama, Y. Kurata, and Y. Matsuzawa. 1994. Identification of molecular defects in a subject with type I CD36 deficiency. Blood. 83:3545-3552.
26. 90-serine) in CD36 cDNA accounts for CD36 deficiency. J. Clin. Invest. 95:1040-1046.
27. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
28. Nozaki, S., M. Kubo, H. Sudo, Y. Matsuzawa, and S. Tarui. 1986. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein-postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals. Metab. Clin. Exp. 35:53-58.
29. Ishigami, M., S. Yamashita, N. Sakai, T. Arai, K. Hirano, H. Hiraoka, K. Kameda, and Y. Matsuzawa. 1994. Large and cholesteryl ester-rich high density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. 116:257-262.
30. Bilheimer, D. W., D. Steinberg, and R. I. Levy. 1972. The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observation. Biochim. Biophys. Acta. 260:212-221.
31. Ueyama, Y., S. Nozaki, K. Yanagi, H. Hiraoka, T. Nakagawa, N. Sakai, S. Jiao, S. Yamashita, and Y. Matsuzawa. 1994. Familial hypercholesterolemia-like syndrome with apolipoprotein E-7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases. J. Intern. Med. 235:169-174.
32. Tomiyama, Y., T. Tsubakio, R. S. Piotrowicz, Y. Kurata, J. C. Loftus, and T. J. Kunicki. 1992. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood. 79:2303-2312.
33. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
34. Goldstein, J. L., and M. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J. Biol. Chem. 249:5153-5162.
35. Heider, J. G., and R. L. Boyett. 1978. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19:514-518.
36. Miyazaki, A., A. T. M. A. Rahim, T. Ohta, Y. Morino, and S. Horiuchi. 1992. High density lipoprotein mediates selective reduction in cholesteryl esters from macrophage foam cells. Biochim. Biophys. Acta. 1126:73-80.
37. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-B1, a CD36-related class B scavenger receptor. J. Biol. Chem. 269:21003-21009.
38. Ottnad, E., S. Parthasarathy, G. R. Sambrano, M. P. Ramprasad, O. Quehenberger, N. Kondratenko, S. Green, D. Steinberg. 1995. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc. Natl. Acad. Sci. USA. 92:1391-1395.
39. Steinberg, D. 1990. Arterial metabolism of lipoproteins in relation to atherogenesis. Ann. NY Acad. Sci. 598:125-135.
40. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N. J. Freedman, G. M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster overy cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88:4931-4935.